110401 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae; Human Immunodeficiency Virus, HIV; Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
SYNCITIN-1 FUSION PROTEINS AND USES THEREOF FOR CARGO DELIVERY INTO TARGET CELLS
#2DIFFERENTIAL CXCR4 EXPRESSION ON HEMATOPOIETIC PROGENITOR CELLS VERSUS STEM CELLS DIRECTS HOMING AND LONG-TERM ENGRAFTMENT
#3CELL-TO-CELL DELIVERY OF RNA CIRCUITS
#4ENGINEERED BACTERIOPHAGE T4 NANOPARTICLES AS A POTENTIAL TARGETED ACTIVATOR OF HIV-1 LATENCY IN CD4+ HUMAN T-CELLS
#5VIRUS-LIKE PARTICLES AND METHODS OF USE THEREOF
#6RETROVIRAL PARTICLE COMPRISING AT LEAST TWO ENCAPSIDATED NONVIRAL RNAS
#7Method and system for inactivating virus infectivity for producing live-attenuated vaccines
#8Virus-like particle (VLP) based small molecule-protein interaction trap
#9Virus-like particle (VLP) based small molecule-protein interaction trap
#10Method and system for inactivating virus infectivity for producing live-attenuated vaccines
#11LENTIVIRAL TRIPLEX DNA, AND VECTORS AND RECOMBINANT CELLS CONTAINING LENTIVIRAL TRIPLEX DNA
#12LENTIVIRAL TRIPLEX DNA, AND VECTORS AND RECOMBINANT CELLS CONTAINING LENTIVIRAL TRIPLEX DNA
#13Retroviral particle comprising at least two encapsidated nonviral RNAs
#14Virus-like particle (VLP) based small molecule-protein interaction trap
#15Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
#16Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
#17Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
#18Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
#19MEDICAL TREATMENT DEVICE FOR TREATING AIDS BY UTILIZING MODIFIED HUMAN IMMUNODEFICIENCY VIRUS VIRIONS TO INSERT ANTI-VIRAL MEDICATIONS INTO T-HELPER CELLS
#20Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA